Hematopoietic stem cell transplantation after first marrow relapse of non-T, non-B acute lymphoblastic leukemia: A Pediatric Oncology Group pilot feasibility study

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 4, 2006, Pages 210-215

  Sandler, Eric S ^a   Homans, Alan ^b   Mandell, Lynda ^b   Amylon, Michael ^b   Wall, Donna A ^b   Devidas, Meenakshi ^b   Buchanan, George R ^b   Lipton, Jeffrey M ^b   Billett, Amy L ^b  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b NONE

Author keywords

Acute lymphoblastic leukemia; Hematopoietic stem cell transplant; Immunotoxin

Indexed keywords

ASPARAGINASE; CD45 ANTIGEN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IDARUBICIN; IFOSFAMIDE; IMMUNOTOXIN; MESNA; METHOTREXATE; PREDNISONE; RICIN; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; ORGAN DONOR; PHYSICIAN; PRIORITY JOURNAL; SIBLING; TIME SERIES ANALYSIS; TRANSPLANT COORDINATOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PILOT PROJECTS; RECURRENCE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33646929826     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212902.84146.81     Document Type: Article

References (31)

1. Pui CH. Childhood leukemias. N Engl J Med. 1995;332:1618-1630.
2. Hoelzer D. Treatment of ALL. Semin Hematol. 1994;31:1-15.
3. Chessels JM. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol. 1998;102:423-438.
4. Wheeler K, Richards S, Bailey C, et al. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UK ALLX experience. Medical Research Council Working Party on Childhood Leukaemia. Br J Haematol. 1998;101:94-103.
5. Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse: The Children's Cancer Group Experience. Cancer. 1998;82:1387-1395.
6. Lawson SE, Harrison G, Richards S, et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study. Br J Haematol. 2000;108:531-543.
7. Barrett AJ, Howrowitz MM, Pollock BH, et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Eng J Med. 1994;331:1253-1258.
8. Hoogenbrugge PM, Gentsen EJA, Does-Vandensberg A, et al. Case control analysis of allogeneic bone marrow transplantation vs. maintenance chemo for relapsed ALL. Bone Marrow Transplant. 1995;15:255-259.
9. Johnson Fl. Role of BMT in childhood acute lymphoblastic leukemia. Hematol Oncol Clin NA. 1990;4:997-1008.
10. Weisdorf DDJ, Billett AAL, Hannan P, et al. Autologous vs unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood. 1997;90:2962-2968.
11. Balduzzi A, Gaipa G, Bonanomi S, et al. Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinic and molecular remissions. Leukemia. 2001;15:50-56.
12. Vaidya SJ, Atra A, Bahl S, et al. Autologous bone marrow transplantation for childhood acute lympoblastic leukemia in second remission long-term follow-up. Bone Marrow Transplant. 2000;25:599-603.
13. Covella AM. Autologous bone marrow transplant in acute lymphoblastic leukemia: biological and clinical aspects. Haematologica. 1990;75:79-83.
14. Billett AL, Sallen SE. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging. Am J Pediatr Hematol Oncol. 1993;15:162-186.
15. Herve P, Labopin M, Plouvier E, et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a European survey. Bone Marrow Transplant. 1991;8:72-75.
16. Kernan YA, Bartech G, Ash RC. Analysis of 462 BMT from unrelated donors facilitated by the National Marrow Donor Program. N Eng J Med. 1993;328:593-602.
17. Casper J, Camitta B, Truitt R. Unrelated bone marrow transplant for children with leukemia or myelodysplasia. Blood. 1995;85:2354-2363.
18. Balduzzi A, Gooley T, Anasetti L, et al. Unrelated donor marrow transplant in children. Blood. 1995;86:3247-3256.
19. Oakhill A, Pamphilon DH, Potter MN, et al. Unrelated done bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol. 1996;94:547-548.
20. Rubinstein P, Carrier C, Scaradavou A, et al. Outcome among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1568-1577.
21. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373-381.
22. Soiffer RJ, Roy DC, Gonin R, et al. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant. 1993;12:243-251.
23. Storb R, Deeg HJ, Pepe M, et al. Methotrexate and cyclosporine vs. cyclosporine alone for prophylaxis of graft-vs-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood. 1989;6:1729.
24. Carella AM, Gaozza E, Congiu A, et al. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. Ann Hematol. 1991;62:156-159.
25. Yeager AM, Vogelsang GB, Jones R, et al. Induction of cutaneous graft-vs-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood. 1992;79:3031-3035.
26. Roy DC, Gyger M, Belanger R, et al. Engraftment following autologous bone marrow transplant with anti B4-BR depletion for patients with B-cell malignancies. Blood. 1993;82:A312.
27. Roy DC, Perreault C, Belanger R, et al. Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin. J Clin Imnumol. 1995;15:51-57.
28. Billett AL, Dornmehl E, Tarbell NJ, et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood. 1993;81:1651-1657.
29. Singhal S, Henslee-Downey PJ, Powles R, et al. Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone Marrow Transplant. 2003;31:889-895.
30. Egerer G, Goldschmidt H, Zoz M, et al. Autologous bone marrow transplantation in adult patients with acute lymphoblastic leukemia. Leuk Lymphoma. 2003;44:9-14.
31. Houtenbos I, Bracho F, Davenport V, et al. Autologous bone marrow transplantation for childhood acute lympoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs. leukemia effect, and post-transplant immuno-and chemotherapy (PTIC). Bone Marrow Transplant. 2001;27:145-153.